Page last updated: 2024-10-24

myeloid cell apoptotic process

Definition

Target type: biologicalprocess

Any apoptotic process in a myeloid cell, a cell of the monocyte, granulocyte, mast cell, megakaryocyte, or erythroid lineage. [CL:0000763, GOC:add, GOC:mtg_apoptosis, PMID:11292031, PMID:15330259, PMID:17133093]

Myeloid cell apoptosis is a tightly regulated process that eliminates unwanted or damaged myeloid cells, ensuring immune homeostasis and preventing uncontrolled inflammation. It involves a cascade of molecular events leading to the dismantling of the cell.

**Initiation:**
- **Extrinsic pathway:** This pathway is triggered by external signals, such as death receptor activation (e.g., TNF-α, Fas ligand) on the cell surface. Binding of these ligands leads to the formation of death-inducing signaling complex (DISC) and activation of caspase-8.
- **Intrinsic pathway:** This pathway is activated by intracellular stress signals, such as DNA damage, oxidative stress, or growth factor deprivation. These signals trigger the release of cytochrome c from mitochondria into the cytoplasm, leading to the formation of the apoptosome and activation of caspase-9.

**Execution:**
- **Caspase activation:** Both pathways converge on the activation of caspase-3, a key executioner caspase. Once activated, caspase-3 cleaves and activates other caspases, initiating a cascade of proteolytic events.
- **Cellular dismantling:** Activated caspases dismantle the cell, leading to characteristic apoptotic features:
- **Nuclear fragmentation:** Caspase-activated DNase (CAD) degrades DNA, resulting in the characteristic ladder-like pattern seen on DNA electrophoresis.
- **Cell shrinkage:** Cells lose volume and become more compact due to the degradation of the cytoskeleton and other cellular components.
- **Blebbing:** The cell membrane forms bulges (blebs) as the cytoskeleton collapses.
- **Apoptotic body formation:** The apoptotic cell fragments into membrane-bound vesicles (apoptotic bodies) containing cellular debris.

**Phagocytosis:**
- Apoptotic bodies are rapidly recognized and engulfed by phagocytes, such as macrophages. This prevents the release of intracellular contents and inflammation.

**Regulation:**
- Myeloid cell apoptosis is tightly regulated by a complex interplay of pro- and anti-apoptotic factors.
- Pro-apoptotic proteins (e.g., Bax, Bak) promote the release of cytochrome c from mitochondria.
- Anti-apoptotic proteins (e.g., Bcl-2, Bcl-xL) inhibit this release and promote cell survival.

**Importance:**
- Myeloid cell apoptosis is crucial for maintaining immune homeostasis, preventing autoimmunity, and regulating inflammation.
- Dysregulation of apoptosis can contribute to the development of various diseases, including cancer, autoimmune disorders, and infections.
- Understanding the molecular mechanisms of myeloid cell apoptosis is crucial for developing novel therapeutic strategies for these diseases.'
"

Proteins (4)

ProteinDefinitionTaxonomy
Ubiquitin carboxyl-terminal hydrolase BAP1A ubiquitin carboxyl-terminal hydrolase BAP1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q92560]Homo sapiens (human)
Signal transducer and activator of transcription 5BA signal transducer and activator of transcription 5b that is encoded in the genome of human. [PRO:WCB, UniProtKB:P51692]Homo sapiens (human)
Lysosomal acid lipase/cholesteryl ester hydrolaseA lysosomal acid lipase/cholesteryl ester hydrolase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P38571]Homo sapiens (human)
Apoptosis regulator Bcl-2An apoptosis regulator Bcl-2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P10415]Homo sapiens (human)

Compounds (36)

CompoundDefinitionClassesRoles
catechinhydroxyflavan
chlorcyclizinechlorcyclizine: was heading 1964-94 (Prov 1964-73); CHLOROCYCLIZINE & HISTACHLORAZINE were see CHLORCYCLIZINE 1977-94; use PIPERAZINES to search CHLORCYCLIZINE 1966-94; histamine H1-blocker used both orally and topically in allergies and also for the prevention of motion sicknessdiarylmethane
gossypolGossypol: A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer.
alizarindihydroxyanthraquinonechromophore;
dye;
plant metabolite
suramin sodiumsuramin sodium : An organic sodium salt that is the hexasodium salt of suramin. It is an FDA approved drug for African sleeping sickness and river blindness.organic sodium saltangiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
paclitaxelTaxus: Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL).taxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
epigallocatechin gallate(-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin.

epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis)
flavans;
gallate ester;
polyphenol
antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
5,6,7,8-tetrahydro-1-naphthol5,6,7,8-tetrahydro-1-naphthol : 1-naphthol hydrogenated at C-5, -6, -7 and -8.tetralins
epicatechin(-)-epicatechin : A catechin with (2R,3R)-configuration.catechin;
polyphenol
antioxidant
gallocatechol(-)-epigallocatechin : A flavan-3,3',4',5,5',7-hexol having (2R,3R)-configuration.catechin;
flavan-3,3',4',5,5',7-hexol
antioxidant;
food component;
plant metabolite
chelerythrine chloride
epicatechin gallate(-)-epicatechin-3-O-gallate : A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3R)-hydroxy group of epicatechin. A natural product found in Parapiptadenia rigida.

epicatechin gallate: a steroid 5alpha-reductase inhibitor; RN given refers to the (cis)-isomer; structure given in first source; isolated from green tea
catechin;
gallate ester;
polyphenol
EC 3.2.1.1 (alpha-amylase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
blastmycinblastmycin: structureamidobenzoic acid
apogossypolapogossypol: structure in first source
5-(1,3-benzodioxol-5-yl)-N-(2-furanylmethyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamidepyrazolopyrimidine
umi-77UMI-77: an Mcl-1 inhibitor; structure in first source
4-(4-ethoxycarbonylanilino)-2-quinazolinecarboxylic acid ethyl esterquinazolines
N-[2-(4-acetyl-1-piperazinyl)phenyl]-2-(5-methyl-2-propan-2-ylphenoxy)acetamidepiperazines
thioguanine anhydrousThioguanine: An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.

tioguanine : A 2-aminopurine that is the 6-thiono derivative of 2-amino-1,9-dihydro-6H-purine. Incorporates into DNA and inhibits synthesis. Used in the treatment of leukaemia.
2-aminopurinesanticoronaviral agent;
antimetabolite;
antineoplastic agent
nf 449
ixabepilone1,3-thiazoles;
beta-hydroxy ketone;
epoxide;
lactam;
macrocycle
antineoplastic agent;
microtubule-destabilising agent
abt-737aromatic amine;
aryl sulfide;
biphenyls;
C-nitro compound;
monochlorobenzenes;
N-arylpiperazine;
N-sulfonylcarboxamide;
secondary amino compound;
tertiary amino compound
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
nutlin-3anutlin 3: an MDM2 antagonist; structure in first sourcestilbenoid
N-[4-(2-tert-butylphenyl)sulfonylphenyl]-2,3,4-trihydroxy-5-[(2-propan-2-ylphenyl)methyl]benzamidebenzamides
MI-63MI-63 : An azaspiro compound resulting from the formal fusion of position 3 of 6-chloro-oxindole with position 3 of (2R,3SS5S)-3-(3-chloro-2-fluorophenyl)-5-(2,2-dimethylpropyl)-N-[2-(morpholin-4-yl)ethyl]pyrrolidine-2-carboxamide. It is a potent inhibitor of the MDM2-p53 interaction.azaspiro compound;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
oxindoles;
pyrrolidines;
secondary carboxamide
apoptosis inducer
navitoclaxaryl sulfide;
monochlorobenzenes;
morpholines;
N-sulfonylcarboxamide;
organofluorine compound;
piperazines;
secondary amino compound;
sulfone;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
lalistat 2
abt-199venetoclax : A member of the class of pyrrolopyridines that is a potent inhibitor of the antiapoptotic protein B-cell lymphoma 2. It is used for treamtment of chronic lymphocytic leukemia with 17p deletion.

venetoclax: A BCL-2 inhibitor with antineoplastic activity that is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA associated with chromosome 17p deletion; structure in first source.
aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
N-sulfonylcarboxamide;
oxanes;
pyrrolopyridine
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
nvp-cgm097NVP-CGM097: an MDM2 and HDM2 inhibitor; structure in first source
jy-1-106JY-1-106: a BH3 alpha-helix mimetic that functions as a pan-Bcl-2 inhibitor; structure in first source
a-1155463A-1155463: a Bcl-X(L) inhibitor; structure in first source
bm-1197BM-1197: inhibits both Bcl-xL and Bcl-2; has antineoplastic activity
a-1331852A-1331852: a Bcl-X(L) inhibitor; structure in first source
BDA-366BDA-366 : A member of the class of anthraquinone that is 1,4-diamino-9,10-anthraquinone in which the two amino groups are carrying 3-(diethylamino)-2-hydroxypropyl and (oxiran-2-yl)methyl substituents. It exhibits anti-cancer properties.

BDA-366: has antineoplastic activity; binds Bcl-2 protein; structure in first source
anthraquinone;
epoxide;
secondary alcohol;
secondary amino compound;
tertiary amino compound
antineoplastic agent;
apoptosis inducer
4-[[2-[(6-methyl-4-oxo-1H-pyrimidin-2-yl)thio]-1-oxoethyl]amino]benzoic acid ethyl esteramidobenzoic acid
apogossypoloneapogossypolone: has antineoplastic activity; structure in first source